Vanda Pharmaceuticals Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Vanda Pharmaceuticals Inc 公司

Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Vanda Pharmaceuticals Inc简介



公司代码VNDA

公司名称Vanda Pharmaceuticals Inc

上市日期Apr 12, 2006

CEOPolymeropoulos (Mihael Hristos)

员工数量368

证券类型Ordinary Share

年结日Apr 12

公司地址Suite 300E

城市WASHINGTON

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编20037

电话12027343400

网址https://www.vandapharma.com/

公司代码VNDA

上市日期Apr 12, 2006

CEOPolymeropoulos (Mihael Hristos)

Vanda Pharmaceuticals Inc公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Mihael Hristos Polymeropoulos, M.D.

Chairman of the Board, President, Chief Executive Officer

2.34M

+10000.00%

Mr. Gunther Birznieks

Senior Vice President - Business Development

411.63K

+174050.00%

Mr. Kevin Patrick Moran

Chief Financial Officer, Senior Vice President, Treasurer

329.46K

+178386.00%

Mr. Richard W. Dugan

Lead Independent Director

177.45K

+59225.00%

Dr. Tage Honore, Ph.D.

Independent Director

123.47K

+59225.00%

Ms. Anne Sempowski Ward

Independent Director

119.07K

+59225.00%

Dr. Stephen Ray Mitchell, M.D.

Independent Director

97.08K

+52225.00%

Mr. Timothy I. Williams

Senior Vice President, General Counsel, Secretary

--

Ms. Phaedra S. Chrousos

Independent Director

--

Mr. Joakim (Kim) Wijkstrom

Senior Vice President, Chief Marketing Officer

--

名称

名称/职务

职务

持股

持股变动

Dr. Mihael Hristos Polymeropoulos, M.D.

Chairman of the Board, President, Chief Executive Officer

2.34M

+10000.00%

Mr. Gunther Birznieks

Senior Vice President - Business Development

411.63K

+174050.00%

Mr. Kevin Patrick Moran

Chief Financial Officer, Senior Vice President, Treasurer

329.46K

+178386.00%

Mr. Richard W. Dugan

Lead Independent Director

177.45K

+59225.00%

Dr. Tage Honore, Ph.D.

Independent Director

123.47K

+59225.00%

Ms. Anne Sempowski Ward

Independent Director

119.07K

+59225.00%

收入明细

单位: USD更新时间: 1月6日周二

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Fanapt

31.25M

55.54%

Hetlioz

17.98M

31.96%

PONVORY

7.04M

12.50%

由于公司未披露，未能获取相关数据

业务

地区

业务USD

名称

营收

占比

Fanapt

31.25M

55.54%

Hetlioz

17.98M

31.96%

PONVORY

7.04M

12.50%

股东统计

更新时间: 2月4日周三

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

9.77%

The Vanguard Group, Inc.

6.26%

Renaissance Technologies LLC

5.88%

Dimensional Fund Advisors, L.P.

4.34%

Tang Capital Management, LLC

3.98%

其他

69.76%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

9.77%

The Vanguard Group, Inc.

6.26%

Renaissance Technologies LLC

5.88%

Dimensional Fund Advisors, L.P.

4.34%

Tang Capital Management, LLC

3.98%

其他

69.76%

股东类型

持股股东

占比

Investment Advisor

28.50%

Investment Advisor/Hedge Fund

26.41%

Hedge Fund

17.28%

Individual Investor

7.19%

Private Equity

2.47%

Research Firm

1.71%

Pension Fund

0.27%

Bank and Trust

0.20%

Sovereign Wealth Fund

0.19%

其他

15.76%

机构持股



更新时间: 1月1日周四

报告期

机构数

持股数

持股占比

持股变动

2025Q4

346

45.82M

77.53%

-10.46M

2025Q3

373

46.45M

78.60%

-9.99M

2025Q2

417

50.75M

85.90%

-11.31M

2025Q1

426

48.51M

82.37%

-12.27M

2024Q4

444

46.48M

79.71%

-15.23M

2024Q3

446

47.42M

81.36%

-14.93M

2024Q2

445

46.99M

80.73%

-18.42M

2024Q1

434

53.50M

92.97%

-11.41M

2023Q4

445

55.38M

96.27%

-9.21M

2023Q3

446

56.79M

98.75%

-12.15M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

5.77M

9.77%

-211.76K

-3.54%

Sep 30, 2025

The Vanguard Group, Inc.

3.56M

6.02%

+14.34K

+0.40%

Sep 30, 2025

Renaissance Technologies LLC

3.48M

5.88%

+29.46K

+0.85%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

2.56M

4.34%

-21.79K

-0.84%

Sep 30, 2025

Tang Capital Management, LLC

2.35M

3.98%

--

Sep 30, 2025

Polymeropoulos (Mihael Hristos)

2.34M

3.95%

+10.00K

+0.43%

Aug 07, 2025

BlackRock Financial Management, Inc.

2.25M

3.8%

-186.40K

-7.66%

Sep 30, 2025

Acadian Asset Management LLC

2.23M

3.77%

+496.85K

+28.69%

Sep 30, 2025

Millennium Management LLC

3.25M

5.5%

+130.50K

+4.18%

Sep 30, 2025

Two Sigma Investments, LP

1.57M

2.66%

+235.54K

+17.63%

Sep 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

iShares Neuroscience and Healthcare ETF

0.49%

Invesco NASDAQ Future Gen 200 ETF

0.49%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.12%

ALPS Medical Breakthroughs ETF

0.1%

Federated Hermes MDT Small Cap Core ETF

0.09%

iShares Micro-Cap ETF

0.05%

ProShares Ultra Nasdaq Biotechnology

0.04%

Franklin US Small Cap Multifactor Index ETF

0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.04%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.03%

iShares Neuroscience and Healthcare ETF

占比0.49%

Invesco NASDAQ Future Gen 200 ETF

占比0.49%

SPDR SSGA US Small Cap Low Volatility Index ETF

占比0.12%

ALPS Medical Breakthroughs ETF

占比0.1%

Federated Hermes MDT Small Cap Core ETF

占比0.09%

iShares Micro-Cap ETF

占比0.05%

ProShares Ultra Nasdaq Biotechnology

占比0.04%

Franklin US Small Cap Multifactor Index ETF

占比0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.04%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

占比0.03%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据